Methylene blue gel for skin cancer not treated by surgery or radiation
Part of Cancer clinical trials.
This trial tests a methylene blue gel for people with certain types of basal cell carcinoma (a common skin cancer) who cannot have surgery or radiation. The goal is to see if the gel can treat the cancer safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of morpheaform, infiltrative, or noduloulcerative basal cell carcinoma (specific types of skin cancer)
- You are 18 years of age or older
- You have multiple skin lesions, each smaller than 2 cm (about the size of a pea)
- You cannot or choose not to have surgery or radiation, and other injected treatments are not an option for you
- You are not pregnant or breastfeeding
- You have no history of heart disease, blood clots, bleeding problems, or severe allergic reactions to methylene blue
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new methylene blue formula injected into skin cancer tumors that cannot be removed by surgery or treated with radiation. It is for people who have one or more small tumors (each less than 2 cm) and cannot have the usual treatments.
This trial tests if methylene blue can help people who develop side effects called CRS or ICANS after treatments like CAR-T cells or bispecific antibodies. It is a first-in-human study to find a safe dose.
This trial tests whether a blue dye (methylene blue) applied directly to burn wounds and activated with light can help fight infection. It's designed for people with moderate to deep burns that will require several dressing changes.
This trial tests a new treatment that combines light (photodynamic therapy) and sound (sonodynamic therapy) to treat a common type of skin cancer called nodular basal cell carcinoma. The goal is to see if this combination works better than light alone for small tumors.
This Phase 1/2 trial tests EscharEx (an investigational treatment) to see if it is safe and works on a single small basal cell skin cancer on the trunk or upper arms. You might qualify if your cancer fits specific size and location rules and you have not had radiation to that spot.
This trial tests a combination of blue-light therapy (a type of photodynamic therapy) and an oral medication called sonidegib for people with multiple basal cell carcinomas (BCCs). It may be an option if you have several BCCs that are not suitable for surgery or radiation, or if you prefer not to have surgery.
Hear when a new Inoperable Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.